¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀå º¸°í¼ : Á¦Ç°, ¿¬·ÉÃþ, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)
Smart Syringe Market Report by Product, Age Group, Application, End User (Hospitals and HMOs, Diabetic Patients, Family Practices, Psychiatrics, and Others), and Region 2024-2032
¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀå ±Ô¸ð´Â 2023³â 95¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC ±×·ìÀº ½ÃÀåÀÌ 2032³â±îÁö 173¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̸ç, 2024³â°ú 2032³â »çÀÌ¿¡ 6.63%ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.
½º¸¶Æ® ÁÖ»ç±â´Â Àç»ç¿ëÀ» ¹æÁöÇÏ°í ¾ÈÀüÇÏÁö ¾ÊÀº ÁÖ»ç ¹æ¹ýÀ» ±ÔÁ¦ÇÏ´Â ¾ÈÀü ¸ÞÄ¿´ÏÁòÀ» °®Ãá ÀÇ·á±â±âÀÔ´Ï´Ù. ÇÁ¸®¼Â ÆÄ¶ó¹ÌÅÍ, »ç¿ë ¹üÀ§, »ç¿ë »óȲ ÃßÀû ±â´ÉÀ» °®Ãá Àбâ/¾²±â ĨÀÌ ³»ÀåµÇ¾î ÀÖ½À´Ï´Ù. ÀÚµ¿ ºñȰ¼ºÈ(AD), ¼öµ¿ ¾ÈÀü ¹× Ȱ¼º ¾ÈÀü ÁÖ»ç±âÀÇ º¯ÇüÀÌ ÀϹÝÀûÀÔ´Ï´Ù. Àΰ£ ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º(HIV), AÇü °£¿°, BÇü °£¿°, ´ç´¢º´ µî ½É°¢ÇÑ Áúȯ°ú Áõ»óÀ» °¡Áø ȯÀÚÀÇ Ä¡·á¿¡ µµ¿òÀÌ µË´Ï´Ù. ¿¹¹æ Á¢Á¾, ¾à¹° Àü´Þ, Ç÷¾× ½Ã·á äÃë µî¿¡ »ç¿ëµË´Ï´Ù. ±× °á°ú ¼¼°èÀÇ º´¿ø, Áø·á¼Ò, Áø´Ü¼Ò, ¿¹¹æ Á¢Á¾ ¼¾ÅÍ¿¡¼ ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù.
½º¸¶Æ® ÁÖ»ç±â ½ÃÀå µ¿Çâ :
´ëÁßµé »çÀÌ¿¡¼ ¸¸¼º Áúȯ°ú ¹ÙÀÌ·¯½º °¨¿°ÀÇ À¯ÇàÀÌ Áõ°¡ÇÏ´Â °ÍÀº ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ¼ö¿ä¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ½É°¢ÇÑ ÀÇ·á Áúȯ¿¡ °É¸®±â ½¬¿î °í·ÉÈ Àα¸ Áõ°¡¿¡µµ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ´ëÁßµé »çÀÌ¿¡¼ Ç÷¾×À» ¸Å°³·Î ÇÏ´Â °¨¿°ÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÚ°¡ÁÖ»çÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î ħħ »ç°í¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁö°í ¾ÈÀüÇÑ ÁÖ»ç¹ý¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö¸é¼ ÀÌ ¾÷°è¿¡¼ »ç¾÷À» Àü°³ÇÏ´Â ´ë±â¾÷¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. °Ô´Ù°¡, Ãâ»ý¼öÀÇ È®´ë¿Í û¼Ò³â »çÀÌ¿¡¼ ´Ù¾çÇÑ ¼Ò¾Æ ÁúȯÀÇ À¯º´·üÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ, ½ÃÀå¿¡ ¹àÀº Àü¸ÁÀ» °¡Á®¿À°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦Ç° Á¦Á¶¾÷ü´Â °£´ÜÇÑ ¸ð´ÏÅ͸µÀ» À§ÇØ ÅÍÄ¡ ½ºÅ©¸° ¹× Wi-Fi ȣȯ ¼ÒÇü ¹× Æí¸®ÇÑ °æ·® ¼Ö·ç¼ÇÀ» µµÀÔÇß½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ÀÇ·á ÀÎÇÁ¶ó ¹× ÀÇ·á ¼ºñ½º °³¼±¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ±¤¹üÀ§ÇÑ Á¶»ç °³¹ß(R&D) Ȱµ¿ÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·ç´Â ÁÖ¿ä Áú¹®
- 2023³â ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀå ±Ô¸ð´Â?
- 2024³â-2032³â ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
- ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
- ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâÀº?
- ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀåÀÇ Á¦Ç°º° ³»¿ªÀº?
- ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀåÀÇ ¿¬·ÉÃþº° ³»¿ªÀº?
- ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀåÀÇ ¿ëµµº° ³»¿ªÀº?
- ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀåÀÇ ÃÖÁ¾ »ç¿ëÀÚº° ³»¿ªÀº?
- ½º¸¶Æ® ÁÖ»ç±â ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
- ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?
¸ñÂ÷
Á¦1Àå ¼¹®
Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý
- Á¶»çÀÇ ¸ñÀû
- ÀÌÇØ°ü°èÀÚ
- µ¥ÀÌÅÍ ¼Ò½º
- ½ÃÀå ÃßÁ¤
- Á¶»ç ¹æ¹ý
Á¦3Àå ÁÖ¿ä ¿ä¾à
Á¦4Àå ¼Ò°³
Á¦5Àå ¼¼°èÀÇ ½º¸¶Æ® ÁÖ»ç±â ½ÃÀå
- ½ÃÀå °³¿ä
- ½ÃÀå ½ÇÀû
- COVID-19ÀÇ ¿µÇâ
- ½ÃÀå ¿¹Ãø
Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç°º°
- ÁÖ»ç±â¸¦ ÀÚµ¿ ¹«È¿È
- ¾×Ƽºê ¾ÈÀü ÁÖ»ç±â
- ÆÐ½Ãºê ¾ÈÀü ÁÖ»ç±â
Á¦7Àå ½ÃÀå ºÐ¼® : ¿¬·ÉÃþº°
Á¦8Àå ½ÃÀå ºÐ¼® : ¿ëµµº°
- ¾à¹°Àü´Þ
- ¿¹¹æÁ¢Á¾
- Ç÷¾× °Ëü äÃë
Á¦9Àå ½ÃÀå ³»¿ª : ÃÖÁ¾ »ç¿ëÀÚº°
- º´¿ø°ú HMO
- ´ç´¢º´ ȯÀÚ
- °¡Á¤ ÀÇ·á(ÀÇ»ç)
- Á¤½ÅÀÇÇÐ
- ±âŸ
Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°
- ºÏ¹Ì
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- Çѱ¹
- È£ÁÖ
- Àεµ³×½Ã¾Æ
- ±âŸ
- À¯·´
- µ¶ÀÏ
- ÇÁ¶û½º
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ·¯½Ã¾Æ
- ±âŸ
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ½ÃÀå µ¿Çâ
- ½ÃÀå ºÐ¼® : ±¹°¡º°
- ½ÃÀå ¿¹Ãø
Á¦11Àå SWOT ºÐ¼®
Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®
Á¦13Àå Porter's Five Forces ºÐ¼®
- °³¿ä
- ±¸¸ÅÀÚÀÇ Çù»ó·Â
- °ø±Þ±â¾÷ÀÇ Çù»ó·Â
- °æÀïµµ
- ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
Á¦14Àå °¡°Ý ºÐ¼®
Á¦15Àå °æÀï ±¸µµ
- ½ÃÀå ±¸Á¶
- ÁÖ¿ä ±â¾÷
- ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
- AdvaCare Pharma
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Gerresheimer AG
- Merit Medical Systems Inc.
- Nipro Corporation
- Numedico Technologies Pty Ltd.
- Retractable Technologies Inc.
- Terumo Corporation
BJH
The global smart syringe market size reached US$ 9.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.63% during 2024-2032.
A smart syringe is a medical device engineered with safety mechanisms to prevent reuse and regulate unsafe injection practices. It is incorporated with a read and write chip with preset parameters, ranges, and usage tracking. It is commonly available in variants of auto-disable (AD), passive safety, and active safety syringes. It aids in treating patients with critical disorders and conditions, such as human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and diabetes. It is used for vaccination, drug delivery, and blood specimen collection. As a result, it is utilized in hospitals, clinics, diagnostics, and vaccination centers across the globe.
Smart Syringe Market Trends:
The increasing prevalence of chronic diseases and viral infections among the masses represents one of the major factors positively influencing the demand for smart syringes around the world. It can also be attributed to the growing aging population, which is more prone to severe medical diseases. Moreover, the expanding number of blood-borne infections among the masses is favoring the market growth. In addition, the rising demand for self-injecting medicines is contributing to the market growth. Apart from this, increasing concerns about needle stick injuries and the rising awareness about safe injection practices are offering lucrative growth opportunities to leading players operating in the industry. Furthermore, the expanding number of births and the growing prevalence of various pediatric diseases among adolescents are creating a positive outlook for the market. Additionally, product manufacturers are introducing small-sized, convenient, lightweight with touch screens and Wi-Fi-enabled solutions for easy monitoring. Besides this, rising investments in improving healthcare infrastructure and medical services and extensive research and development (R&D) activities are expected to propel the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global smart syringe market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, age group, application and end user.
Breakup by Product:
Auto-disable Syringes
Active Safety Syringes
Passive Safety Syringes
Breakup by Age Group:
Pediatrics
Adults
Breakup by Application:
Drug Delivery
Vaccination
Blood Specimen Collection
Breakup by End User:
Hospitals and HMOs
Diabetic Patients
Family Practices (Physicians)
Psychiatrics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AdvaCare Pharma, B. Braun Melsungen AG, Becton, Dickinson and Company, Gerresheimer AG, Merit Medical Systems Inc., Nipro Corporation, Numedico Technologies Pty Ltd., Retractable Technologies Inc. and Terumo Corporation.
Key Questions Answered in This Report
- 1. What was the size of the global smart syringe market in 2023?
- 2. What is the expected growth rate of the global smart syringe market during 2024-2032?
- 3. What are the key factors driving the global smart syringe market?
- 4. What has been the impact of COVID-19 on the global smart syringe market?
- 5. What is the breakup of the global smart syringe market based on the product?
- 6. What is the breakup of the global smart syringe market based on age group?
- 7. What is the breakup of the global smart syringe market based on the application?
- 8. What is the breakup of the global smart syringe market based on the end user?
- 9. What are the key regions in the global smart syringe market?
- 10. Who are the key players/companies in the global smart syringe market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Smart Syringe Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Auto-disable Syringes
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Active Safety Syringes
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Passive Safety Syringes
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Age Group
- 7.1 Pediatrics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Adults
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Drug Delivery
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Vaccination
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Blood Specimen Collection
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals and HMOs
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Diabetic Patients
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Family Practices (Physicians)
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Psychiatrics
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 AdvaCare Pharma
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 B. Braun Melsungen AG
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 SWOT Analysis
- 15.3.3 Becton, Dickinson and Company
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Gerresheimer AG
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.5 Merit Medical Systems Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Nipro Corporation
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Numedico Technologies Pty Ltd.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Retractable Technologies Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.9 Terumo Corporation
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis